Prognosis in juvenile diabetes mellitus. III. Significance of outpatient control. a cost-benefit analysis
Deckert, T.; Poulsen, J.E.; Larsen, M.
Ugeskrift for Laeger 140(16): 899-901
1978
ISSN/ISBN: 0041-5782 PMID: 418544 Document Number: 134674
Document emailed within 1 workday
Related Documents
Semler, P.; Werner, U. 1976: Diabetes mellitus and microcirculation. Significance of diabetic angiopathy for the prognosis and course of diabetes mellitus, possibilities and bases of angiologic therapy Fortschritte der Medizin 94(7): 354-357Land, W. 1982: Pancreas transplantation. Current significance in the treatment of juvenile diabetes mellitus Münchener Medizinische Wochenschrift 124(4): 71-73
Duff, P.; Dolphin, C. 2007: Cost-benefit analysis of assistive technology to support independence for people with dementia – Part 2: Results from employing the ENABLE cost-benefit model in practice Technology and Disability 19(2-3): 79-90
Ratzmann, K.P.; Raskovic, M.; Thoelke, H. 1992: Significance of proteinuria and hypertension in the prognosis of Type Ii diabetes mellitus Zeitschrift für Arztliche Fortbildung 86(1-2): 31-36
Tursunov, B.; Mazovetskiĭ, A.G.; Zavadskiĭ, P.S. 1978: Disturbed glucose tolerance and diabetes mellitus in the relatives of patients with the juvenile form of diabetes mellitus Problemy Endokrinologii 24(5): 13-16
Czech, A.; Jagielińska-Kalinowska, E. 1991: Statistical-clinical analysis of arterial blood pressure in the outpatient clinic population of patients with diabetes mellitus Polski Tygodnik Lekarski 46(1-3): 7-13
Swenson, L.; Audell, L.; Hedhammar, A. 1997: Prevalence and inheritance of and selection for hip dysplasia in seven breeds of dogs in Sweden and benefit: cost analysis of a screening and control program Journal of the American Veterinary Medical Association 210(2): 207-214
Costa Mestanza, C.J.; Fernández Fernández, I.; Carmona de Torres, I.; Durán García, S. 1989: Evaluation of diabetes knowledge in patients with insulin-dependent diabetes mellitus. Influential factors and analysis of its relation with blood glucose control Revista Clinica Espanola 185(3): 113-118
Joshi, M.D.; Amayo, E.O. 2006: Cardiovascular risk factors in patients with type 2 diabetes mellitus in Kenya: levels of control attained at the Outpatient Diabetic Clinic of Kenyatta National Hospital, Nairobi East African Medical Journal 83(7): 405-6; author reply 406-7
Joshi, M.D.; Amayo, E.O. 2006: Cardiovascular risk factors in patients with type 2 diabetes mellitus in Kenya: levels of control attained at the Outpatient Diabetic Clinic of Kenyatta National Hospital, Nairobi East African Medical Journal 83(7): 405-6; author reply 406-7
Zhong, Y.; Wu, X. 2020: Effects of cost-benefit analysis under back propagation neural network on financial benefit evaluation of investment projects Plos one 15(3): E0229739
Swenson, L.; Audell, L.; Hedhammar, A. 1997: Prevalence and inheritance of and selection for elbow arthrosis in Bernese mountain dogs and Rottweilers in Sweden and benefit: cost analysis of a screening and control program Journal of the American Veterinary Medical Association 210(2): 215-221
Deirdre Wulf 1981: Cost-Benefit and Cost-Effectiveness Analysis for Family Planning Programs International Family Planning Perspectives 7(4): 141-144
Knudtzon, J.; Meen, H.D.; Baevre, H.; Søvik, O. 1983: Children and adolescents with diabetes mellitus. Understanding diabetes mellitus in relation to treatment and control Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 103(5): 511-515
Merritt, T.A.; Hallman, M.; Vaucher, Y.; McFeeley, E.; Tubman, T.R. 1990: Impact of surfactant treatment on cost of neonatal intensive care: a cost-benefit analysis Journal of Perinatology: Official Journal of the California Perinatal Association 10(4): 416-419
Fuller, J.F. 1974: Cost-benefit and cost-effectiveness analysis New Zealand Dental Journal 70(322): 282-288
Leowski, K.; Leowski, J. 1979: Cost and benefit prognosis from tuberculosis treatment programs in Poland in the years 1975-2000 Pneumonologia Polska 47(1): 3-10
Likitmaskul, S.; Wekawanich, J.; Wongarn, R.; Chaichanwatanakul, K.; Kiattisakthavee, P.; Nimkarn, S.; Prayongklin, S.; Weerakulwattana, L.; Markmaitree, D.; Ritjarean, Y.; Pookpun, W.; Punnakanta, L.; Angsusingha, K.; Tuchinda, C. 2002: Intensive diabetes education program and multidisciplinary team approach in management of newly diagnosed type 1 diabetes mellitus: a greater patient benefit, experience at Siriraj Hospital Journal of the Medical Association of Thailand 85 Suppl. 2: S488-S495
Mori, A.Thomas.; Kampata, L.; Musonda, P.; Johansson, K.Arne.; Robberstad, B.; Sandøy, I. 2017: Cost-benefit and extended cost-effectiveness analysis of a comprehensive adolescent pregnancy prevention program in Zambia: study protocol for a cluster randomized controlled trial Trials 18(1): 604
Liebl, A.; Goertz, A.; Henkel, B.; Spannheimer, A. 2000: Costly type 2 diabetes mellitus. Does diabetes cost 20 billion per year? MMW Fortschritte der Medizin 142(23): 39-42